PRVA
Privia Health Group, Inc.23.81
-0.53-2.18%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
AI unlocks margin upside
Q&A unpacked AI investments in Gemini, athenahealth, Navina, and pilots across corporate functions, physician workflows, and care delivery, with Parth targeting the high end of 30-35% EBITDA margins or better. Evolent ACO integration follows Privia's playbook to lift savings rates over time, accretive to 20% growth sans new deals. Ambulatory utilization stays elevated despite ACA/Medicaid churn, buffered by diversification. Free cash flow reigns supreme, but 80% conversion reflects full cash taxes. Capital prioritizes M&A compounding; buybacks lurk as last resort. Management stayed crisp on execution. Investors eye AI traction, Evolent synergies.
Key Stats
Market Cap
2.93BP/E (TTM)
170.07Basic EPS (TTM)
0.14Dividend Yield
0%Recent Filings
10-K
FY2025 results
Privia Health drove FY2025 revenue to $2.12B, up 22% y/y, with Practice Collections hitting $3.47B (+17%) on 5,380 implemented providers (12% y/y growth) and 1.54M attributed lives (+23%). Q4 accelerated momentum via Arizona market entry and Evolent ACO acquisition adding 120K lives, boosting capitated revenue 45% y/y to $308M and shared savings 31% to $235M. Care Margin expanded to 21.8% ($462M) while Platform Contribution Margin hit 50.8%, fueling Adjusted EBITDA of $126M (39% y/y growth). Cash at $480M supports $125M revolver availability. Regulatory shifts in Medicare/Medicaid threaten VBC momentum.
8-K
Crushed 2025 guidance, eyes 20% growth
Privia Health crushed 2025 guidance, posting $2.1B revenue (up 22.3%), $125.5M Adjusted EBITDA (up 38.8%), and $163.4M operating cash flow with $479.7M cash, zero debt. Implemented providers hit 5,380; attributed lives soared 22.7% to 1.54M. Cash fuels the engine. 2026 guidance eyes ~20% EBITDA growth amid tough Medicare Advantage winds.
8-K
ACO acquisition closes
10-Q
Q3 FY2025 results
Privia Health posted Q3 revenue of $580.4M, up 32.5% y/y from $437.9M, with operating income tripling to $14.4M from $5.8M on stronger FFS patient care and shared savings fueled by a $23.8M accrual adjustment. Diluted EPS held at $0.05 despite dilution from 128.8M shares, matching y/y growth. Arizona market entry closed April 2025 for $89.1M net cash, adding $30.6M goodwill and $64.4M payer/physician intangibles. Cash sits at $441.4M with $125M revolver undrawn; ops cash flow hit $35.9M YTD. Revenue hinges on three payers over 10%.
8-K
Q3 crushes, guidance up
Privia Health crushed Q3 with revenue up 32.5% to $580.4M, net income +94.1% to $6.9M, and Adjusted EBITDA soaring 61.6% to $38.2M versus 2024. Implemented providers hit 5,250, up 13.1%; practice collections jumped 27.1% to $940.4M. Signed deal to buy Evolent's ACO for $100M cash plus up to $13M contingent, adding 120,000 lives; raised FY'25 guidance across metrics. Cash stays strong at $441.4M.
IPO
Website
Employees
Sector
Industry
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
EVH
Evolent Health, Inc
4.07-0.05
FORA
Forian Inc.
2.14+0.00
LVCE
LIVECARE INC
0.01+0.00
PAXH
PreAxia Health Care Payment Sys
0.22+0.00
PHR
Phreesia, Inc.
16.35-0.35
PIII
P3 Health Partners Inc.
4.59-0.36
PINC
Premier, Inc.
28.26+0.00
TBRG
TruBridge, Inc.
22.25-0.27